Masimo (MASI) Akcie Kurz
Masimo Kurz
Za posledních 19 let vzrostly tržby Masimo o 10,6 % ročně a dosáhly 1,53 Mld. USD. Zisk na akcii klesal o 11,0 % ročně za posledních 17 let. U Masimo je čistá marže -9,9 % dolů oproti 18,5 % před několika lety. Při dnešní ceně vychází dividendový výnos zhruba na 0,56 %. Výplatní poměr je kolem 93 % zisku. Konsenzuální 12měsíční cílová cena pro Masimo je 183,60 USD, asi nad cenu o 2,0 %. Z 16 analytiků jich 12 doporučuje nákup — celkový konsenzus je Koupit.
Cena akcie Masimo
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Masimo a analýza akcií
Nejčastější otázky týkající se akcie Masimo
The business model of Masimo Corp focuses on providing innovative noninvasive monitoring technologies. Masimo develops and manufactures a wide range of medical devices and sensors to improve patient outcomes and reduce healthcare costs. The company's flagship product, Masimo SET®, revolutionized pulse oximetry by offering accurate measurements even in challenging conditions. With a dedication to patient safety and care, Masimo Corp combines advanced signal processing and sensor technology to deliver reliable monitoring solutions to healthcare professionals. Through their product portfolio, Masimo Corp aims to enhance patient care and promote efficiency in the healthcare industry.
Masimo Corp is primarily active in the medical device industry.
The main competitors of Masimo Corp in the market include companies such as Philips Healthcare, Nihon Kohden Corporation, and Smiths Medical.
Masimo Corp is a leading global medical technology company specializing in noninvasive patient monitoring. Founded in 1989 by Joe Kiani, the company has a rich history of innovation and advancements in the healthcare industry. Masimo Corp's core business revolves around developing and manufacturing advanced monitoring technologies, including pulse oximeters and signal extraction technology. With its commitment to improving patient outcomes and reducing healthcare costs, Masimo Corp has revolutionized the way healthcare professionals monitor patients' vital signs. Today, it is recognized as a trusted name in the medical device industry, providing innovative solutions that enhance patient care and safety worldwide.
Masimo Corp has achieved several significant milestones. Some noteworthy accomplishments include the development of breakthrough technologies in noninvasive patient monitoring, such as SET® pulse oximetry. The company has also received numerous awards and recognition for its innovative products and contributions to the healthcare industry. Masimo Corp has successfully expanded its global presence and formed strategic partnerships with leading healthcare organizations worldwide. Additionally, the company has consistently shown strong financial performance and steady revenue growth over the years. Overall, Masimo Corp continues to make strides in advancing patient care through its cutting-edge technologies and industry leadership.
Masimo Corp is primarily present in various countries and regions across the globe. Some notable markets where the company operates include the United States, European countries like Germany, France, and the United Kingdom, as well as Asian countries including Japan and China. Masimo Corp's global presence enables it to provide its innovative healthcare solutions, including noninvasive patient monitoring technologies, to healthcare facilities and professionals worldwide.
Masimo Corp represents a strong commitment to improving patient outcomes and reducing healthcare costs through innovative medical technologies. The company values include a dedication to patient safety, quality, and continuous improvement. Masimo's corporate philosophy revolves around providing noninvasive monitoring solutions that enable clinicians to make more informed decisions, enhance patient care, and optimize workflows. By combining advanced sensor and signal processing technologies, Masimo Corp strives to address the evolving needs of the medical community. The company's focus on research and development, as well as collaboration with healthcare professionals, reinforces its commitment to pioneering advancements in medical monitoring to benefit patients worldwide.
Analytici aktuálně stanovují průměrnou cílovou cenu 180,21 USD pro akcii Masimo (medián: 183,60 USD), tedy +0,1 % vůči poslední ceně. Konsensus vychází z 16 hodnocení analytiků.
15 analytiků aktuálně hodnotí akcii Masimo: 7 doporučuje koupit, 8 držet a 0 prodat. Pro rok 2026 analytici očekávají u Masimo tržby 1,63 Mld. USD a zisk na akcii 5,97 USD.
Při aktuálním kurzu se akcie Masimo obchoduje za 160,09 EUR (179,95 USD).
Akcie Masimo (MASI) je kótována na 8 burzách, mimo jiné: NYSE (MASI), London (0JZ2.L), SIX (Zürich) (3M4.SW), Frankfurt (3M4.F), München (3M4.MU), Düsseldorf (3M4.DU).
Masimo Corporation is a leading provider of medical diagnostic and monitoring technologies that aim to make patient care safer and more effective. The company is headquartered in California and operates offices worldwide. Masimo's business model can be roughly divided into three areas: 1. Products and technologies Masimo offers a wide range of medical devices and technologies, including pulse oximeters for monitoring oxygen saturation in the blood, capnographs for monitoring end-tidal carbon dioxide concentration, as well as patient monitors and control systems. A highlight is Masimo's Signal Extraction Technology (SET), which is used in almost all of the company's products. SET uses a special algorithm to filter signals from skin color, movement, and other external sources of interference, allowing for accurate measurements. Additionally, Masimo has developed other innovative technologies, such as automatic measurement of hemoglobin levels, which can lead to improved patient outcomes. 2. Services Masimo also offers various services, such as installation, training, and technical support for its products. Furthermore, the company has entered into partnerships with other companies such as Apple and Philips to jointly develop innovative solutions for patient monitoring. 3. Research and development Masimo invests heavily in the research and development of new products and technologies. The company has filed numerous patents and successfully implemented them. By collaborating with clinics and universities, Masimo ensures that its products have informative features and high quality that meet the needs of patients and medical professionals. Overall, Masimo's business model is designed to make healthcare safer and more effective by developing innovative products and technologies, and by providing services and support to its customers. The wide range of products and technologies, as well as the investments in research and development, indicate that Masimo will continue to play an important role in the medical industry in the future.
Tržby očekávané za Masimo činí 1,63 Mld. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk očekávané za Masimo činí 323,74 Mil. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Masimo je aktuálně 30,13. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Masimo.
Poměr ceny k tržbám (P/S) Masimo je aktuálně 5,97. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Masimo.
Score kvality pro Masimo je 4/10.
ISIN Masimo je US5747951003. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Masimo je 578074. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Masimo je MASI. Symbol tickeru se používá k obchodování akcií Masimo na burze.
Masimo akcie
Masimo Peer Group
Masimo Ticker
Masimo FIGI
Všechny fundamentální údaje o Masimo v podrobné analýze
Naše analýzy akcií společnosti Masimo zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Masimo. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: